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Secondarybacterialinfectioninhumansisoneofthepathologicalconditionsrequiringclinicalattention.In
this study, we examined the effect of lipopolysaccharide (LPS) on encephalomyocarditis virus (EMCV)
infectedmice.AllmiceinoculatedwithEMCVat5daysbeforeLPSchallengediedwithin24 h.LPS-induced
TNF-amRNAexpressionwas significantlyincreased inthebrainand heartat 5days afterEMCVinfection.
CD11b
1/TLR4
1 cell population in the heart was remarkably elevated at 5 days after EMCV infection, and
sorted CD11b
1 cells at 5 days after EMCV infection produced a large amount of TNF-a on LPS stimulation
in vivo and in vitro. In conclusion, we found that the infiltration of CD11b
1 cells into infected organs is
involved in the subsequent LPS-induced lethal shock in viral encephalomyocarditis. This new experimental
model can help define the mechanism by which secondary bacterial infection causes a lethal shock in viral
encephalomyocarditis.
P
olymicrobial infectious diseases show the involvement of 2 or more microbes, including viruses, bacteria,
fungiorparasites,andthesemicrobesactsynergisticallytomediatecomplexdiseaseprocesses.Inparticular,
a bacterial infection superimposed over an acute viral infection such as influenza is well known as the
aggravation factor in the infectious disease
1,2. Lipopolysaccharide (LPS), the outer membrane of gram-negative
bacteria, causes systemic inflammatory response syndrome, endotoxic shock, disseminated intravascular coagu-
lationandmulti-organfailure
3,4.LPSisrecognizedbyToll-likereceptor4(TLR4)-expressingimmunocompetent
cells, mainly monocytes and macrophages, and induces the production of inflammatory cytokines through NF-
kB activation
3. Toxic effects of LPS are partially induced by the release and action of macrophage-derived
inflammatory cytokines. Especially,the massproduction of tumor necrosis factor-a (TNF-a)causesseptic shock
with an abrupt reduction in blood pressure, leading to rapid aggravation of the disease condition
5,6. It is known
thatLPS-inducedlethalshockiscausedbyalargequantityofTNF-aproducedbyimmunecellsactivatedbysome
kind of pre-stimulation
7,8.
Encephalomyocarditis virus (EMCV), which is a single-stranded RNA virus and a member of Cardiovirus in
thePicornaviridaefamily,causesacutemyocarditisandencephalitisinvariousanimalspecies
9,10.Insomereports,
including our previous study, the death of mice by EMCV infection of high density (500 plaque-forming units
(pfu)) occurred after 6 days, and the mice that survived for 12 days subsequently recovered. Additionally,
remarkable inflammation in the brain and heart occurred at around 6 days after EMCV infection, and thereafter
theinflammationreducedasthedaysprogressed.Hence,theseresultssuggestedthatinflammatorycellsreachthe
activating stage around 6 days after EMCV infection
11–13. It was also demonstrated that various cells under the
activating stage augment reactivity to LPS stimulation
14–16. Previous studies showed that TNF-a is produced in
large quantities by subsequent LPS stimulation during adenovirus infection
17, lymphocytic choriomeningitis
virus, and varicella-zoster virus infection
18, but the original source of TNF-a is not elucidated. Moreover, it is
unknown how LPS affects in the viral encephalomyocarditis. The aim of our study is to examine the effect of LPS
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which possibly produce TNF-a, into the heart in this model.
Results
Survival of mice after LPS stimulation during EMCV infection.
The mice were intraperitoneally inoculated with 20 pfu of EMCV
and were intravenously injected with 10 mg LPS at 0, 2, and 5 days
aftertheEMCVinoculation.At5daysafterEMCVinfection,allmice
died after LPS treatment within 24 h, but the mice subjected to this
treatment at 0 and 2 days after EMCV infection were alive (Table 1).
Moreover,at 5days afterEMCV infection, LPS-induced lethal shock
developed in the mice in an LPS dose-dependent manner (Table 2).
To compare the survival rate between WT and TNF-a KO mice
after LPS treatment during EMCV infection, the mice were treated
intravenouslywith10mgLPSat5daysafterEMCVinfection.AllWT
mice died after LPS treatment within 24 h at 5 days after EMCV
infection, whereas TNF-a KO mice did not die. Moreover, LPS-
inducedlethalityinWTmicewasimprovedbyanti-TNF-aantibody
(100 mg/mouse) treatment before LPS stimulation (Table 3).
EffectofEMCVinfectiononLPS-inducedTNF-aproduction.The
concentration of serum TNF-a was measured at 0, 2, and 8 h after
LPS treatment in each EMCV infection period. LPS-induced TNF-a
concentration in the serum was markedly increased at 5 days after
EMCVinfectionthanat0and2daysafterEMCVinfection(Fig.1A).
ForthelocalizationofTNF-aproduction,TNF-amRNAexpress-
ion was determined in the brain, heart, liver, lung, and spleen at 0, 1,
and 8 h after LPS treatment. TNF-a mRNA expression in the brain,
heart, and liver of mice was significantly increased at 5 days after
EMCV infection as compared with that at 0 and 2 days after EMCV
infection (Fig. 1B).
HistopathologicalfindingandviralloadofthetissuesafterEMCV
infection.Histologicalchangeswereobservedinthebrainandheart.
The mice were inoculated intraperitoneally with 20 pfu of EMCV.
Neuronal cell death and the presence of some inflammatory cells in
hippocampusorbrainsurfaceofthebrainandmarkedinfiltrationof
inflammatory cells in the heart were seen at 5 days after EMCV
infection. The infiltrating cells mainly included macrophages and
neutrophils (Fig. 2A). In the liver, a little infiltration of inflam-
matory cells was observed at 5 days after EMCV infection, and no
remarkable changewasseen inthelung during eachinfection period
(Data not shown). All tissues at 8 h after LPS treatment in EMCV-
infected mice were not observed the significant increase of
inflammatory cells in comparison with the tissues before LPS
treatment (data not shown).
We measured the viral load in the brain, heart, liver, lung and
spleen at2 and5 daysafter EMCVinfection. Viral loads in all tissues
at 5 days after EMCV infection were increased as compared with
those at 2 days after EMCV infection. In particular, viral loads in the
brain and heart markedly increased at 5 days after the infection
(Fig. 2B).
Effect of EMCV infection on mRNA expression of chemokines in
the tissues. Chemoattractant protein-1 (MCP-1) is a major chemo-
attractant responsible for the recruitment of macrophages
19,20.
macrophage inflammatory protein-2 (MIP-2) and keratinocyte-
derived chemokine (KC), which are produced by macrophages,
exhibit potent neutrophil chemotactic activity
21,22. Because the
infiltrated cells were mainly composed of macrophages and
neutrophils as revealed by histopathological findings (Fig. 2A), the
mRNA expressions of MCP-1, MIP-2, and KC were determined in
the brain and heart at 0, 2, and 5 days after EMCV infection. The
mRNA expression of these chemokines in the brain and heart on
5 days after EMCV infection was significantly up-regulated as
compared with that at 0 and 2 days after EMCV infection (Fig. 3).
MCP-1 mRNA expression at 5 days after EMCV infection was 808-
fold in the brain and 125-fold in the heart based on 0 days. Similarly,
MIP-2 mRNA expression was enhanced 254-fold in the brain and
44-foldintheheart,andKCmRNAexpressionwasincreased23-fold
in the brain and also in the heart. Although the expression of
chemokines in the liver, lung and spleen had a tendency to up-
regulated at 5 days after EMCV infection, the up-regulation was
not more remarkable than that in the brain or heart.
Effect of EMCV infection on TLR4 mRNA expression in tissues
and infiltrating cells in the heart. The expression of TLR4 mRNA
was examined in the brain, heart, liver, lung and spleen at 0, 2, and 5
days after EMCV infection. TLR4 mRNA expression in the brain,
heart, and liver at 5 days after EMCV infection was significantly
increased. On the other hand, TLR4 mRNA expression in the lung
and spleen showed no significant change after viral infection
(Fig. 4A).
Next,wedeterminedthephenotypeofmononuclearcells(MNCs)
from the heart at 5 days after EMCV infection. Although a lot of
CD11b
1TLR4
1 cells were contained in MNCs from the heart at 5
daysafterEMCVinfection,fewCD11c
1,CD3
1,CD19
1andCD49b
1
cells were contained (Fig. 4B).
LPS-inducedTNF-aproductioninCD11b
1cellsfromtheheartin
vivo and in vitro. Because MNCs from the heart at 5 days after
EMCV infection were mainly occupied by CD11b
1 cells, we
evaluated the ability of LPS-induced TNF-a production in CD11b
1
cells in vivo. The mice were intravenously inoculated with brefeldin
A (250 mg/mouse) and LPS (10 mg/mouse) at 5 days after EMCV
infection, and MNCs from the heart were harvested at 1 h after LPS
treatment. TNF-a producing cell in gated CD11b
1cells on the basis
of isotype control were increased by LPS treatment (Fig. 5A).
Table 1 | Effect of LPS on lethality in EMCV-infected mice
Mouse Days
a LPS (mg) Lethality (dead/total)
Wild-type 0 10 0/10
Wild-type 2 10 0/10
Wild-type 5 10 10/10
aDays after EMCV infection.
Table 2 | Effect of various dose of LPS on lethality
Mouse Days
a LPS (mg) Lethality (dead/total)
Wild-type 5 0 0/8
Wild-type 5 1 1/8
Wild-type 5 5 6/8
Wild-type 5 10 8/8
aDays after EMCV infection.
Table 3 | Effect of LPS on lethality in TNF-a KO mice and wild-type
mice treated with anti-TNF-a antibody
Mouse Days
a LPS (mg) Lethality (dead/total)
Wild-type 0 10 0/8
Wild-type 5 10 8/8
TNF-a KO 0 10 0/8
TNF-a KO 5 10 0/8
Wild-type 5 10 0/5
1 anti-TNF-a Ab
aDays after EMCV infection.
www.nature.com/scientificreports
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treatment ineach EMCV infection period (A). TNF-a mRNA expression inthe brain, heart, liver, lung, and spleen at 0,1, and8 hafter LPS treatment in
each EMCV infection period wasdetermined on the basis of18S rRNA expression using real-time RT-PCR. The data were calculated referring to mRNA
levelsoftherespectivetissuesincontrolmice(0daysafterEMCVinfection,0 hoursafterLPSinoculation)(B).Thedataarerepresentedasmeans6SDof
the results of 4 mice in each group. *p,0.05
Figure 2 | HistopathologicalfindingandviralloadofthetissuesafterEMCVinfection. Histopathologicalexaminationinthebrainandheartat0,2and
5daysafterEMCVinfectionwasperformed.Tissuesectionsweredeparaffinized,stainedwithhematoxylin-eosin,andexaminedunderlightmicroscopy.
Scalebars,200mm(low-powerfield)and50mm(high-powerfield).Theseexperimentswereperformedwith4miceineachgroupandproducedthesame
results (A). Viral RNA in the brain, heart, liver, lung, and spleen at 0, 2, and 5 days after EMCV infection was analyzed by real-time RT-PCR and was
determinedonthebasisof18SrRNAexpression.Thedataarerepresentedasmeans6SDoftheresultsof4miceineachgroup.Thestatisticalanalysiswas
performed by comparing with Day 2 (B). *p,0.05
www.nature.com/scientificreports
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1 and CD11b
- cells from the heart at 5 days after EMCV
infection were isolated by magnetic cell sorting. Isolated cells and
total cells before isolation were cultured at 1310
5 cells/200 mL with
LPS(1mg/mL) for24 h.LPS-induced TNF-aproduction in CD11b
1
cells was significantly increased as compared with that in total cells
and CD11b
2 cells. CD11b
2 cells could not produce TNF-a after LPS
stimulation (Fig. 5B).
Discussion
In this study, we demonstrated that LPS treatment at 5 days after
EMCVinfectioninducesanexcessofTNF-aproductioninthebrain
and heart and lethal shock (Table 1, Fig. 1). Because this lethal effect
of LPS was cancelled out in TNF-a KO mice infected with EMCV
(Table 3), it is likely that TNF-a from the brain and heart plays a
critical role in the lethal effect of LPS on EMCV infection. Septic
shock is characterized by hypotension, decreased systemic vascular
resistance and impaired vascular reactivity, and TNF-a has been
implicated as a principal mediator in the pathogenesis of septic
shock
23.TNF-aismainlyproducedbymacrophagesintheperipheral
tissue after pathogen infection, and is involved in the elimination of
pathogens from the host
24,25. A protective role of TNF-a in EMCV-
infected mouse model is previously reported
11. In contrast, an ex-
cessive production of TNF-a induces hypothermia, hypotension,
multiple organ failure, septic shock, and death
5,6. In particular, pre-
vious reports demonstrated that the macrophages treated with some
pre-stimulantsproducealargeamountofTNF-aonsubsequentLPS
stimulation. Propionibacterium acnes, an anaerobic gram-positive
bacterium, exerts strong immunomodulatory activities, and partici-
pates in the formation of intrahepatic granulomas and induction
of hypersensitivity for LPS in mice. Additionally, these activi-
ties depended on the recognition of bacteria via TLR9 and subse-
quent IL-12-mediated IFN-c production
26,27. EMCV infection also
Figure 3 | EffectofEMCVinfectiononmRNAexpressionofchemokinesinthetissues. TheexpressionofMCP-1(A),MIP-2(B)andKC(C)mRNAin
thebrain, heart,liver,lung andspleenat0,2and5daysafter EMCVinfection wasanalyzedby real-timeRT-PCRandwasdetermined onthebasis of18S
rRNAexpression.ThedatawerecalculatedreferringtomRNAlevelsoftherespectivetissuesincontrolmice(Day0).Thedataarerepresentedasmeans6
SD of the results of 6 mice in each group. *p,0.05
www.nature.com/scientificreports
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roadinthebrainandheart(Fig.1B,2B).Namely,thesusceptibilityto
LPS was enhanced in the EMCV-infected site.
TLR4 recognizes LPS from gram-negative bacteria, and its recog-
nition is essential for the activation of the innate immune system. In
humans with myocarditis, TLR4 mRNA is also increased in the
heart
28. In the present study, the mRNA expression of TLR4 in the
brain, heart, and liver was increased after EMCV infection (Fig. 4A),
and a significant increase in TNF-a mRNA expression was also
confirmed after subsequent LPS stimulation (Fig. 1B). Histological
findings revealed neuronal cell death and the presence of some
inflammatory cells in hippocampus or brain surface of the brain,
remarkable infiltration of inflammatory cells in the heart, and a little
infiltration of inflammatory cells in the liver at 5 days after EMCV
infection; further, the infiltrating cells were mainly composed of
macrophages and neutrophils. These results indicate that the accu-
mulation of inflammatory cells in the heart after EMCV infection is
associated with this lethal septic shock model. In fact, there is a
correlation between TLR4 mRNA expression and the number of
infiltrated TLR4 positive cells in the heart. A previous report also
Figure 4 | Effect of EMCV infection on TLR4 mRNA expression in tissues and infiltrating cells in the heart. The expression TLR4 mRNA in the brain,
heart, liver, lung, and spleen at 0, 2, and 5 days after EMCV infection was analyzed by real-time RT-PCR and was determined on the basis of 18S rRNA
expression.ThedatawerecalculatedreferringtomRNAlevelsoftherespectivetissuesincontrolmice(Day0).Thedataarerepresentedmeans6SDfrom
4 mice of each group (A). Following reaction with anti-CD16/CD32 antibody to suppress nonspecific binding, MNCs from the heart were stained with
anti-CD3e, anti-CD11b, anti-CD11c, anti-CD19, anti-CD49b and anti-TLR4 antibody. The positive rate of the cells was made on the basis of isotype
control. The data are representative of three separate experiments (B). *p,0.05
www.nature.com/scientificreports
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trationofTLR4-positiveleukocytesintotheliverinanIL-17-induced
multiple tissue inflammation model
29. Furthermore, our previous
studies proved the infiltration of TLR4-positive leukocytes into the
liver on a-galactosylceramide administration and the excessive res-
ponse to subsequent LPS stimulation
8,15. In this study, CD11b
1/
TLR4
1 cells in the heart increased at 5 days after EMCV infection,
but few CD11c
1, CD3
1, CD19
1 and CD49b
1 cells were contained
(Fig.4B).LPS-inducedTNF-awasmainlyproducedbyCD11b
1cells
in the heart at 5 days after EMCV infection in vivo and in vitro
(Fig. 5). Therefore, it is suggested that the infiltration of CD11b
1
cells into the heart involves in the up-reguration of TLR4 mRNA
and subsequent LPS induced TNF-a production.
mRNA expression of MCP-1, MIP-2, and KC in the brain and
heart at 5 days after EMCV infection was markedly increased than
that in uninfected mice (Fig. 3). The enhancement of the mRNA
expression of these chemokines, especially MCP-1, may be involved
inthe infiltration ofinflammatory cells into theheart. MCP-1acts as
a potent chemoattractant and activator of monocytes/macro-
phages
19,20. Shiratsuchi etal
30showed thatmacrophages phagocytose
influenza virus-infected HeLa cells in a manner mediated by phos-
phatidylserine that appears on the surfaces of infected cells during
the process of apoptosis. In addition, the inhibition of macrophage
recruitment by MCP-1 augmented alveolar epithelial damage and
apoptosis during influenza pneumonitis
31. Thus, MCP-1 has an
effective rolein viral clearance, but italsomay aggravate lethal shock
by subsequent LPS stimulation under the EMCV-infected state.
Although the mice treated with 500 mg LPS died within 48 to 72 h
in the general LPS-induced shock model
32,33, all mice treated with 10
mg LPS died within 24 hours in our model; this suggests that LPS
susceptibility in mice markedly rises under the EMCV-infected con-
dition. It is known that infection by the influenza virus, coxsackie
virus,andadenovirusareinvolvedintheonsetofviralencephalitisor
myocarditis
34,35, but there are few reports showing the effect of the
secondary bacterial superimposed infection on viral encephalomyo-
carditis and its mechanism. In the present study, even a low-dose of
LPS could cause the lethal septic shock in EMCV-infected mice.
Thus, it is necessary to monitor serum endotoxin levels and prevent
bacterial infection in patients with encephalitis and myocarditis.
Inconclusion,weestablishedasepticshockmodelusingmicewith
viral encephalomyocarditis and demonstrated that the infiltration of
CD11b
1 cells into tissues is involved in this lethal shock. From an
immunological point of view, our animal model is useful for investi-
gating the pathological state of bacterial superimposed infection on
viral encephalomyocarditis.
Methods
Reagents. LPS from Escherichia coli O111:B5 and brefeldin A were purchased from
Sigma-Aldrich (St Louis, MO, USA). Mouse TNF-a antibody (monoclonal rat IgG1)
for neutralize was purchased from R&D Systems (Minneapolis, MN, USA).
Mice. Mouse experiments were performed according to the guidelines of the Animal
Ethics Committee of Gifu University Graduate School of Medicine. C57BL/6J mice
aged approximately 8–10 weeks were obtained from Japan SLC (Hamamatsu, Japan)
and used as wild-type (WT) mice. TNF-a gene knockout (TNF-a KO) mice of a
C57BL/6J background wereproducedbygene targetingas describedpreviously
11,36,37.
Viral inoculation and LPS treatment. A myocarditic variant of EMCV was
generouslyprovidedbyDr.Seto(KeioUniversity,Tokyo,Japan).Thevirusstockwas
stored at 280uC in Hanks’ balanced salt solution (HBSS) with 0.1%BSA required for
use. The mice were inoculated intraperitoneally with 20 pfu of EMCV in 0.2 mL
saline and were treated intravenously with 10 mg LPS in 0.2 mL saline at 0 (non-
infected),2,and5daysaftertheviralinoculationunlessotherwisenoted.Thelethality
was determined at 24 h after LPS treatment. The experiments were performed
according to the institutional guidelines of Gifu University for microbiologic study.
Measurement of serum TNF-a concentration. The concentration of TNF-a in the
serum and culture supernatant was determined using a mouse TNF-a Quantikine
ELISA kit (R&D Systems, Minneapolis, MN, USA), according to the manufacturer’s
recommendations.
Real-time RT-PCR analysis. Real-time RT-PCR was used to quantify the levels of
TNF-a,TLR4,MCP-1,MIP-2,KCmRNA,andEMCVRNA.TotalRNAinthebrain,
heart, liver, lung and spleen was isolated using Isogen (Nippon Gene, Tokyo, Japan)
andtranscribedtocDNAbyusingtheHighcapacitycDNAtranscriptionkit(Applied
Biosystems, Foster City, CA, USA). Purified cDNA was used as the template for real-
timePCRconductedusingpre-designedprimer/probesetsforTNF-a,TLR4,MCP-1,
MIP-2, KC and 18S rRNA (Applied Biosystems), according to the manufacturer’s
recommendations. The determination of EMCV RNA was performed by the use of
theLightCyclerDNAMasterSYBRGreenI(RocheDiagnosticSystems,Indianapolis,
Figure 5 | LPS-inducedTNF-aproductioninCD11b
1cellsfromtheheartinvivoandinvitro. ThemicewereinoculatedintravenouslywithbrefeldinA
(250mg/mouse)andLPS(10mg/mouse)at5daysafterEMCVinfection,andMNCsfromtheheartwereharvestedat1 hafterLPStreatment.MNCswere
stained with anti-CD11b and anti-TNF-a antibody. The data are representative of three separate experiments (A). Isolated CD11b
1 and CD11b
2 MNCs
and total cells before isolation were cultured at 1310
5 cells per 200 mL with LPS (1 mg/mL) for 24 h. The concentration of TNF-a was determined in
culture supernatant. The data are represented means 6 SD in triplicate cultures (B). *p,0.05
www.nature.com/scientificreports
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59-GTCGTGAAGGAAGCAGTTCC-39, antisense,
59-CACGTGGCTTTTGGCCGCAGAGGC-39
11. 18S rRNA was used as an internal
control. Real-time PCR was carried out using a Light-Cycler rapid thermal cycler
system (Roche Diagnostic Systems).
Histologicalexamination.Histopathologicalexaminationofthebrainandheartwas
performed at 0, 2, and 5 days after EMCV infection. The tissues were fixed in 10%
formalin in PBS for 48 h and embedded in paraffin. Tissue sections were
deparaffinized, stained with H&E, and examined under light microscopy.
Cell isolation in heart. Single cells from the heart, particularly non-parenchymal
cells, were isolated in reference to a previous report
38. The heart was minced with
scissors and was shaken with 5 mL HBSS containing collagenase type 2 (600 U/mL)
and deoxyribonuclease I (60 U/mL) (Worthington, Lakewood, NJ, USA) for 30 min
at 37uC. The specimen was filtered through a stainless steel mesh, and red blood cells
were lysed. After washing and filtration through a 70-mm cell strainer, the single cells
were suspended in RPMI 1640 medium (Wako Pure Chemical Industries; Osaka,
Japan) containing 10% heat-inactivated fetal bovineserum (Thermo Fisher Scientific
Inc, Waltham, MA, USA) and cultured at 37uCi na5 %C O 2 atmosphere.
Flow cytometry analysis. MNCs from the heart at 5 days after EMCV infection were
obtainedbycentrifugationofthesinglecellswithFicoll-Conray(IBL,Gunma,Japan).
Flow cytometry was used to evaluate the expression level of CD3, CD11b, CD11c,
CD19, CD49b and TLR4 in MNCs from the heart at 5 days after EMCV infection.
Following reaction with anti-CD16/CD32 antibody to suppress nonspecific binding,
MNCs were stained with FITC-conjugated hamster anti-mouse CD3e antibody
(clone 145-2C11; BD Biosciences, Franklin Lakes, NJ, USA), FITC-conjugated rat
anti-mouseCD11bantibody(cloneM1/70;eBioscience,SanDiego,CA,USA),FITC-
conjugated hamster anti-mouse CD11c antibody (clone HL-3; BD Biosciences),
FITC-conjugated mouse anti-mouse CD19 antibody (clone MB19-1; eBioscience),
FITC-conjugated rat anti-mouse CD49b antibody (clone DX5; eBioscience), and
PE-conjugated rat anti-mouse TLR4/MD2 complex antibody (clone MTS510;
eBioscience). The positive rate of the cells was made on the basis of isotype control.
Thephenotypic characterizationofthecells wascarriedoutusingFACSCantoII(BD
Biosciences).
Intracellularcytokinestaininginvivo.Themicewereintravenouslyinoculatedwith
brefeldin A (250 mg/mouse) and LPS (10 mg/mouse) at 5 days after EMCV infection.
MNCs from the heart at 1 h after LPS treatment were fixed and permeabilized with
the Cytofix/Cytoperm buffer (BD Biosciences) and were stained with PE-conjugated
rat anti-TNF-a antibody (clone MP6-XT22; eBioscience). The cells were analyzed
using FACSCanto II (BD Biosciences).
Isolation of CD11b
1 cells. MNCs from the heart obtained at 5 days after EMCV
infection were separated into CD11b
1 and CD11b
2 cells using anti-CD11b-
conjugated magnetic beads (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany).
The magnetically labeled cells were purified using the QuadroMACS separation unit
attached to a MACS multistand and LS columns (Miltenyi Biotec GmbH).
Statisticalanalysis.Ineachexperiment,theresultswereexpressedasthemean6SD.
The statistical significance of the difference in mean values was determined by
Student’s t test or one-way analysis of variance followed by Scheffe’s test. P values of
less than 0.05 were considered significant.
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